Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Aug 14:7:99.
doi: 10.1186/1746-1596-7-99.

Multifocal Langerhans cell sarcoma involving epidermis: a case report and review

Affiliations
Review

Multifocal Langerhans cell sarcoma involving epidermis: a case report and review

Changsong Wang et al. Diagn Pathol. .

Abstract

Objective: To study the clinico-pathological characteristics of Langerhans cell sarcoma (LCS) which involving epidermis.

Methods: A case of primary multifocal LCS was analyzed in histopathology and immunophenotype.

Results: A 41-year-old man with multifocal cutaneous LCS involving the inguina and waist was reported. Clinical and pathology data were available. Neoplastic cells with markedly malignant cytological features were observed. Tumor cells exhibited irregular shape with abundant and eosinophilic red staining cytoplasm; large, irregular-shaped, showing lobulated or dented nucleus and some cells with a longitudinal nuclear groove and prominent nucleoli. The tumor cells expressed CD1a, Langerin (CD207), S-100 protein, CD68 and vimentin, and did not express pan-T or B cell markers and epithelial markers. The patient died less than 1 year after diagnosis due to local recurrence and metastasis to the lung, despite the administration of local radiation and chemotherapy.

Conclusions: LCS is a tumor with markedly malignant cytological features that originates from Langerhans cells. Primary multifocal neoplasms involving epidermis is even rare. Accurate diagnosis is based on the histopathological and immunohistochemical of the tumor cells.

Virtual slide: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1182345104754765.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hematoxylin-eosin staining of LCS (100×).
Figure 2
Figure 2
Hematoxylin-eosin staining of LCS (200×).
Figure 3
Figure 3
LCS tumor cells expressed Langerin (400×).
Figure 4
Figure 4
LCS tumor cells expressed S-100 protein (400×).
Figure 5
Figure 5
LCS tumor cells expressed CD1a (400×).

Similar articles

Cited by

References

    1. Jaffe E, Harris N, Stein H, In: World Health Organization classification of tumours: Pathology and genetics, tumours of haematopoietic and lymphoid tissues. Barnes L, Eveson JW, Reichart P, Sidransky D, editor. IARC Press, Lyon; 2008. Tumors derived from Langerhans cells; pp. 278–289.
    1. Lee JS, Ko GH, Kim HC. et al.Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report. J Korean Med Sci. 2006;21:577–580. doi: 10.3346/jkms.2006.21.3.577. - DOI - PMC - PubMed
    1. Shi-Yuan He X-LZ. 2 cases of Langerhans cell sarcoma misdiagnosed. J Guangxi Trad Chin Med University. 2000;17:93–95.
    1. Jing Chen J-YT, Ci PAN. et al.Langerhans cell sarcoma: the clinical features and diagnosis. J China Pediatr Blood Cancer. 2007;12:213–214.
    1. Lian YL, He HY, Liao SL. et al.Langerhans cell sarcoma of talus: report of a case. Zhonghua Bing Li Xue Za Zhi. 2006;35:697–698. - PubMed

MeSH terms

Substances